The chicken-and-egg problem: sleep may be an early symptom
The most stubborn limitation is reverse causation: the disease may change sleep before anyone notices memory problems. A nationwide cohort of about 1.5 million people found that those with a hospital-diagnosed sleep disorder had a 17% higher risk of dementia overall, but the excess was concentrated in the first five years after diagnosis (35% higher risk) and disappeared after five years [3]. That pattern is what you would expect if, in many cases, the sleep disorder was an early sign of developing dementia rather than a cause of it. The authors themselves say the findings could point toward sleep disorders as an early symptom, and that more work is needed to separate symptom, risk factor, or both [3].
The same worry shapes other cohorts. In a 10-year analysis of English adults aged 50 and over, researchers deliberately excluded people already showing cognitive impairment to reduce bias from reverse causation, because sleep and activity habits can be altered by preclinical dementia symptoms [5]. That exclusion helps, but it is a partial fix: subtle disease processes can begin long before a test flags impairment, so some contamination may remain.
Other differences between people, and when sleep is measured
Even without reverse causation, people who sleep badly differ from good sleepers in many ways — education, health conditions, mental health, income — and some of these also affect dementia risk. Longitudinal studies are more robust than one-off snapshots, but they still cannot fully account for this residual confounding [1]. The cohort above adjusted for age, sex, calendar year, education at age 50, and physical and psychiatric illness, yet adjustment is never complete [3].
A second, less obvious problem is how exposure is defined. A review of the most recent observational dementia cohorts found that 84 of 116 studies (72%) compared people who already had a given exposure at the start of follow-up with those who did not. That design has ill-defined interventions, invites selection bias, and makes confounder adjustment harder [2]. The review used physical activity as its case study, not sleep, so the exact proportion should not be transferred to sleep research — but the structural problem applies to any exposure measured this way, including sleep habits.
Why randomized trials, the usual tiebreaker, don't settle it either
Randomized controlled trials are the gold standard for causality because randomization balances confounders, but in this field they run into high financial costs, long follow-up periods, and ethical or practical constraints [1]. You cannot practically randomize thousands of people to years of poor sleep, and dementia takes decades to develop.
The result is a field relying on observational cohorts while the causal foundation remains incomplete [1]. Dementia's multifactorial origins and slow, uneven progression make causal questions especially hard, and the advanced causal-inference methods now being applied to observational data vary widely in how rigorously they are used — a variation that a forthcoming systematic review aims to map [4]. That review is a protocol, so it does not yet tell us how well these methods perform; it signals that the field knows its toolkit needs auditing.
What would make the causal case stronger
Several fixes follow directly from the limitations. Measuring sleep in multiple ways — self-reported scales alongside objective polysomnography and actigraphy — and looking across sleep domains rather than only clinical disorders would reduce reliance on any single, error-prone measure [1]. Pairing cognitive tests with MRI-based brain outcomes and focusing on high-risk subgroups would sharpen both exposure and outcome [1].
On the design side, the target trial framework — structuring an observational analysis to mimic the randomized trial that would answer the question — is proposed as a way to overcome the weaknesses of prevalent-exposure designs and improve the robustness of dementia-prevention evidence [2]. None of this guarantees a causal answer, but it narrows the gap between what cohorts can show and what causality requires.
Sources used in this answer
Reconsidering Causal Inference Approaches in Sleep and Dementia.
Causal inference in sleep-dementia research is limited by reverse causation, residual confounding, and the high cost, long follow-up, and ethical or practical constraints of randomized trials.
Moving beyond the prevalent exposure design for causal inference in dementia research
Most recent observational dementia cohort studies (84 of 116, 72%) used a prevalent exposure design, which suffers from ill-defined interventions, selection bias, and difficult confounder adjustment, and a target trial framework is proposed as an alternative.
Hospital‐diagnosed sleep disorders and incident dementia: a nationwide observational cohort study
In a nationwide cohort of 1,491,276 people, any sleep disorder was associated with a 17% higher dementia risk, concentrated in the first five years (35% higher) and non-significant after five years, consistent with sleep disorders possibly being an early dementia symptom.
Causal inference in real-world dementia research: a systematic review protocol
A systematic review protocol aims to assess how rigorously causal inference methods are applied in real-world dementia research and to identify assumptions and gaps, given wide variation in their implementation.
OP64 Joint associations of physical activity and sleep duration with cognitive ageing: longitudinal analysis of an English cohort study
In a 10-year cohort of English adults aged 50 and over, short sleep was associated with faster cognitive decline, and the authors note that preclinical dementia symptoms affecting sleep and activity behaviors are a considerable limitation to causal inference.